Jupiter Neurosciences, Inc.
JUNS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679628
No open-market purchases or sales by Jupiter Neurosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $826.9K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Jupiter Neurosciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 2 | 9 | +7 |
| Shares | 65.0K | 1.36M | +1.29M (+1,990.9%) |
| Value | $66.3K | $2.39M | +$2.33M (+3,508.0%) |
New holders (7)
Institutions that held Jupiter Neurosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vestor Capital, LLC | 970,985 | $1.71M | 0.11% |
| Vanguard Group Inc | 215,831 | $379.9K | 0.00% |
| Geode Capital Management, LLC | 103,815 | $182.7K | 0.00% |
| Northern Trust Corp | 24,819 | $43.7K | 0.00% |
| XTX Topco Ltd | 15,094 | $26.6K | 0.00% |
| Jane Street Group, LLC | 12,392 | $21.8K | 0.00% |
| Bank of America Corp | 121 | $213 | 0.00% |
Sold out (0)
Institutions that held Jupiter Neurosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
None.